Genetics of chronic post-surgical pain: a crucial step toward personal pain medicine

Conclusions Pharmacogenomic technologies and strategies provide an opportunity to expand our knowledge in CPSP treatment that may manifest in a personalized approach to diagnosis, prevention, and therapy. Capitalizing on this genomic knowledge will necessitate the analysis of many tens of thousands of study patients. This will require an international coordinated effort to which anesthesiologists and surgeons can contribute substantially.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research